ACD Labs Logo

Making Lab Data Work Better

Published online at C&EN.

by Poornima Apte, C&EN BrandLab Contributing Writer

C&EN spoke with three Pfizer scientists about their efforts to standardize access to analytical data, and the recent webinar they gave on the topic with ACD/Labs.

Traditionally, sharing the results of an experiment among colleagues is inefficient, with scientists either emailing large files back and forth or manually assembling documents, then passing them along. An alternative approach is to centralize all results into a unified library. Scientists in the structure elucidation group at Pfizer have implemented such a strategy and can now access results from wherever they are. Pankaj Aggarwal, a principal scientist at Pfizer, says, "We can do the data analysis and even control our instruments from home."

Having all a laboratory's data in one place has other benefits, according to David Foley, a senior principal scientist at Pfizer. A scientist unaware of or unable to find data from a particular experiment too often simply runs that test again, wasting time and laboratory resources. A centralized library "removes the duplication of work," Foley says.

Time saved in creating a central library for analytical results is critical because drug discovery and production cycles in the pharmaceutical industry are becoming increasingly compressed. "In the past, projects would take 10–20 years," Aggarwal says. "Now we are talking about products getting to market in 5 years."

Read the full article online at C&EN

Watch the Webinar on Demand

The wealth of analytical information that is generated every day in R&D organizations can provide rich insights, even months after the initial acquisition of data. With this increase in data, however, comes a significant challenge to combine, organize, access, visualize, and mine these informational repositories. In addition to the challenges of the growing volume and complexity of data being collected nowadays, we are also seeing an increasing need to provide context-specific access to information.

In this webinar members of the Analytical Research and Development (Pharmaceutical Sciences Small Molecule) team will describe how Pfizer is addressing these challenges with software designed for the handling and management of assembled, live analytical data. Introducing the concept of a scientific information library that provides fit-for-use access to information, the Pfizer team discusses how ACD/Labs tools are being employed to enhance digital workflows with automated data extraction and processing.

The presentation focuses on the following:

  • Pfizer's vision for making analytical data streams more accessible and re-useable
  • Creating a globally accessible multi-technique analytical data library (including structurally assigned NMR and mass spectrometry data)
  • Benefits and re-use cases for fit-for-use access to chromatography data